ID1 and Kaposi's sarcoma: Chemical inhibition of the BMP-Smad1-Id pathway by Dorsomorphin and WSS25 inhibits the growth of the KSHV-induced tumors, indicating that small inhibitors targeting this pathway can serve as potential therapeutic agents for the treatment of KS.